| Literature DB >> 35457956 |
Shuyuan Wang1, Harri Alenius2,3, Hani El-Nezami1,4, Piia Karisola2.
Abstract
Titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles (NPs) have attracted a great deal of attention due to their excellent electrical, optical, whitening, UV-adsorbing and bactericidal properties. The extensive production and utilization of these NPs increases their chances of being released into the environment and conferring unintended biological effects upon exposure. With the increasingly prevalent use of the omics technique, new data are burgeoning which provide a global view on the overall changes induced by exposures to NPs. In this review, we provide an account of the biological effects of ZnO and TiO2 NPs arising from transcriptomics in in vivo and in vitro studies. In addition to studies on humans and mice, we also describe findings on ecotoxicology-related species, such as Danio rerio (zebrafish), Caenorhabditis elegans (nematode) or Arabidopsis thaliana (thale cress). Based on evidence from transcriptomics studies, we discuss particle-induced biological effects, including cytotoxicity, developmental alterations and immune responses, that are dependent on both material-intrinsic and acquired/transformed properties. This review seeks to provide a holistic insight into the global changes induced by ZnO and TiO2 NPs pertinent to human and ecotoxicology.Entities:
Keywords: (eco)toxicology; Arabidopsis thaliana; C. elegans; animal models (in vivo); cell cultures (in vitro); engineered metal nanoparticles; titanium dioxide; transcriptomics; zebrafish; zinc oxide
Year: 2022 PMID: 35457956 PMCID: PMC9031840 DOI: 10.3390/nano12081247
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.719
Figure 1Interactions of ZnO and TiO2 nanoparticles with biological systems. Upon human-relevant exposures via ingestion, dermal contact and inhalation, ZnO and TiO2 NPs with acquired and/or transformed physicochemical identities, together with material-intrinsic properties, are able to induce various biological processes and pathways. Adapted from “Nanoparticle Interactions with Biological Systems and Vice Versa”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates, accessed 25 March 2022.
Transcriptomic characterization of exposures to ZnO NPs in in vitro and in vivo studies.
| ZnO In Vitro | |||||
|---|---|---|---|---|---|
| Study | Method | Cell Model | Material Properties | Exposure Conditions | Main Transcriptomic Findings |
| [ | RNAseq | Human lung epithelial carcinoma cells | Uncoated 42 nm | 15 μg/mL for 1, 6 or 24 h |
|
| [ | Microarray | Phorbol 12-myristate 13-acetate (PMA)-differentiated | Uncoated, <50 nm | 2 or 8 μg/mL for 4 h | |
| [ | Microarray | Rat alveolar macrophages | Uncoatad, 158 nm | 4 and 17 μg/mL for 4 h | |
| [ | Microarray | Human chronic myeloid leukemia cells (K562 cell line) | Uncoated, ≤40 nm | 40 μg/mL for 15 h | |
| [ | RNAseq | Human skin cancer cells (A431) | Uncoated, around 500 nm | 150 μg/mL for 6 h | |
| [ | Microarray | Human monocyte-derived macrophages; Jurkat T cell leukemia derived cell | Uncoated, 15 nm | 1 or 10 μg/mL for 6 or 24 h |
|
|
| |||||
|
|
|
|
|
|
|
| [ | Microarray (lung) | C57BL/6J BomTac female mice | Uncoated, 100 nm | Intratracheal instillation at 11, 33 or 100 mg/kg once | |
| [ | RNAseq (liver) | CD-1 male mice | Around 35 nm | Oral administration at 25 mg/kg for 8 or 12 weeks |
|
| [ | RNAseq (liver) | Sprague Dawley female rats | Uncoated, 86.3 nm | Oral administration at 100 mg/kg for 14 consecutive days |
|
| [ | RNAseq (cultured skin cell) | CD-1 mice | Around 30 nm | Mouse hair follicle stem cells were exposed at 20 μg/mL for 12 h | |
| [ | RNAseq (liver) | Hairless SKH:QS mice | Uncoated, 18.2 ± 0.4 nm | Dermal application at 2 mg/cm2 to the head, ears, back, sides and tail, for 30 treatments | No statistically significant DEGs |
Transcriptomic characterization of exposures to TiO2 NPs in in vitro and in vivo studies.
| TiO2 In Vitro | |||||
|---|---|---|---|---|---|
| Study | Method | Cell Model | Material Properties | Exposure Conditions | Main Transcriptomic Findings |
| [ | Microarray | Undifferentiated Caco-2 cells | E171; Antase, 15–25 nm | 1.4 μg/cm2 for 2, 4, and 24 h | |
| [ | RNAseq | Human lung epithelial carcinoma cells (A549) | Anatase (80%) and rutile (20%), 21 nm | 800 μg/mL for 24 h | |
| [ | RNAseq | Human glioblastoma cells (T98G) | 18 nm | 20 μg/mL for 72 h | |
|
| |||||
|
|
|
|
|
|
|
| [ | RNAseq (colon) | BALB/c male and female mice | E171 | Oral administration at 5 mg/kg for 2, 7, 14 or 21 days | |
| [ | RNAseq (liver) | CD-1 mice | Anatase (80%) and rutile (20%), 21 nm | Oral administration at 50 mg/kg for 26 weeks |
|
| [ | Microarray (liver) | CD-1 female mice | Anatase, 5–6 nm | Oral administration at 10 mg/kg for 90 days | |
| [ | Microarray (spleen) | CD-1 female mice | Anatase, 7 nm | Oral administration at 10 mg/kg for 90 days | |
| [ | Microarray (ovary) | CD-1 female mice | Anatase, 6 nm | Oral administration at 10 mg/kg for 90 days |
|
| [ | RNAseq (liver) | hairless SKH:QS mice | Anatase (80%) and rutile (20%), 21 nm | Dermal application at 2 mg/cm2 to the head, ears, back, sides and tail, for 30 treatments | No significant changes |
| [ | Microarray (lung) | CD-1 mice | Anatase (80%) and rutile (20%), 21 nm | Intratracheal instillation at 5, 20 or 50 mg/kg once | |
| [ | Microarray (lung) | CD-1 male mice | Rutile, 21 nm | Intratracheal instillation of 0.1 or 0.5 mg once | |
| [ | Microarray (lung and liver) | C57BL/6BomTac female mice | Rutile, 20 nm, coated with polyalcohols | Whole-body inhalation at 42 mg/m3 for 11 days (1 h/day) | |
| [ | Microarray (lung) | CD-1 female mice | Anatase, 6 nm | Nasal instillation at 2.5, 5 or 10 mg/kg for 90 days | |
| [ | Microarray (lung) | C57BL/6 female mice | Rutile, 21 nm, coated with polyalcohols | Intratracheal instillation at 18, 54 or 162 μg/mouse once |
|
| [ | Microarray (lung) | C57BL/6J female mice | Anatase, rutile or anatase/rutile; 8, 20 and 300 nm; and hydrophobic or hydrophilic surface modifications | Intratracheal instillation at 18, 54, 162 or 486 μg/mouse once | |
| [ | Microarray (liver and heart) | C57BL/6 female mice | Rutile, 21 nm, coated with polyalcohols | Intratracheal instillation at 162 μg/mouse once | |
| [ | Microarray (liver) | C57BL/6BomTac female mice | Rutile, 21 nm, coated with polyalcohols | Whole-body inhalation at 42 mg/m3 for 10 days (1 h/day) during gestation |
|
| [ | RNAseq (heart) | Sprague Dawley female rats | Anatase (80%) and rutile (20%), 21 nm | Whole-body inhalation at 10 mg/m3 for 7–8 days (4–6 h/day) during gestation |
|
Transcriptomic characterization of exposures to ZnO and TiO2 NPs in ecotoxicology-related models.
|
| |||||
|
|
|
|
|
|
|
| [ | Microarray | Zebrafish | <50 nm | 4.8 mg/L for 96 h |
|
| [ | Microarray | Zebrafish | Uncoated, 20–30 nm | 0.01, 0.1, 1 or 10 mg/L for 96 h post-fertilization |
|
| [ | Microarray | Zebrafish larva | Uncoated, 10–30 nm | 1 or 4 μmol/L for 72 h post-fertilization |
|
| [ | Microarray |
| Pristine, phosphatized or sulfidized, 30 nm | 0.7 mg/L (ZnO), 7.5 mg/L (pZnO) and 7.5 mg/L (sZnO) for 48 h | |
| [ | Microarray (roots) |
| Uncoated, <100 nm | 100 mg/L for 7 days |
|
| [ | Microarray |
| Uncoated, 20 nm | 4 mg/L for 7 days | |
|
| |||||
|
|
|
|
|
|
|
| [ | Microarray | Zebrafish embryos | Anatase, 25 nm | Microinjections of 8.5 ng/g | |
| [ | Microarray (ovary) | Zebrafish | Anatase, <25 nm | 0.1 and 1 mg/L for 13 weeks | |
| [ | Microarray |
| Anatase, 32 nm | 200 μg/mL for 72 h |
|
| [ | Microarray |
| Anatase (83%) and rutile (17%), 34.1 nm; anatase: 5.9–16.2 nm; rutile: 12.6–68.9 nm | 0.01, 0.1, 1 and 10 mg/L for 24 h |
|
| [ | Microarray (root) |
| Anatase (80%) and rutile (20%), 21 nm | 100 mg/L for 7 days | |
| [ | Microarray | Anatase (80%) and rutile (20%), 21 nm | 500 mg/L for 12 days | ||
Figure 2NP-driven environmental effects studied in different ecotoxicology-related models. Arabidopsis thaliana plants, C. elegans nematodes and Danio rerio zebrafish represent soil and aquatic species that are conventionally used for ecological toxicity assessment. Transcriptomic analyses yield DEGs, which identify the major affected pathways and the associated biological functions. Created with BioRender.com (https://app.biorender.com, accessed 25 March 2022).